Session 13A: Structuring success: Legal, IP and deal-making in global biotech
Tracks
Track 1
| Friday, October 24, 2025 |
| 12:15 PM - 1:00 PM |
| Visionary Room |
Details
Behind every breakthrough lies a web of legal, financial, and strategic frameworks that determine whether innovation can scale globally. This session explores the critical role of intellectual property, deal-making, and cross-border transactions in biotech success. Global Industry experts will unpack how IP strategies underpin valuation, how licensing and partnerships are structured across jurisdictions, and how global capital flows shape company growth. With perspectives spanning legal counsel, executive leadership, and investor relations, the discussion will highlight the interplay between regulation, commercial contracts, and global market entry. Delegates will gain practical insights into how to secure IP, navigate complex deal structures, and build partnerships that ensure Australian biotech innovation can thrive on the global stage.
Speaker
Dr. Helen Mutimer
Head of IP Advisory
FB Rice
Panellist
Dr. Chris Nave
Founding Partner & Managing Director
Brandon Capital
Panellist
Derek Small
Co-Founder & CEO
Syndeio Biosciences
Panellist